BTG $110 million acquisiton of Galil Medical

Overview:

• UK healthcare company BTG acquired Israeli cancer treatment business Galil Medical for $110 million.  
• Listed in New York and London, BTG focuses also focuses on cancer treatments. 
• Galil has developed cryotherapy (compressed, cooled gas) treatments to reduce tumors, a less invasive process than chemotherapy or radiation.  
• BTG paid an initial cash fee of $84.5 million for Galil, and will pay up to $100 million depending on the businesses performance before the end of 2018.  
• BTG funded the acquisition through its cash reserves. 

Ben Naylor - Regional editor